Video

Dr. John Marshall on Differentiating Squamous and Adenocarcinoma in GI Cancers

John L. Marshall, MD, chief, Division Of Hematology/Oncology, Georgetown University Hospital Associate Director, clinical research, Lombardi Comprehensive Cancer Center at Georgetown University Hospital, discusses the difference between squamous and adenocarcinoma in esophageal and gastric cancer.

John L. Marshall, MD, chief, Division Of Hematology/Oncology, Georgetown University Hospital Associate Director, clinical research, Lombardi Comprehensive Cancer Center at Georgetown University Hospital, discusses the difference between squamous and adenocarcinoma in esophageal and gastric cancer.

Squamous cell carcinoma and adenocarcinoma have different causes and molecular makeup in esophageal and gastric cancers, yet they are still being treated as one in the same. Marshall emphasizes that once oncologist differentiate between the 2 types of cancer and treat them individually, there will be better results and improvements in survival.

<<<

View more from the 2016 World Congress on GI Cancer

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Related Videos
Rachel N. Grisham, MD
Toon Van Gorp, MD, PhD
Paul G. Richardson, MD
Kevin Kalinsky, MD, MS, discusses the potential to switch CDK4/6 inhibitors in HR-positive metastatic breast cancer.
Dr Tolaney on Considerations for Adjuvant CDK4/6 Inhibitors in HR+/HER2-Negative Breast Cancer
Dr Jagsi on Factors for RT Omission After Breast-Conserving Surgery in Early Breast Cancer
Dr Borgen on the Need for Improved Risk Stratification in Early-Stage Breast Cancer
Richard T. Lee, MD, Cherng Family Director’s Chair, Center for Integrative Oncology, medical director, clinical professor, Supportive & Integrative Medicine, Department of Supportive Care Medicine, City of Hope
Rachna T. Shroff, MD, MS
Dr Coombs on the Challenges in Establishing a Treatment Consensus for Relapsed CLL